Ocrelizumab 920mg/23ml solution for injection vials
- SNOMED code
43159211000001106- Active compound
- Ocrelizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 23 ml, vial
- Ingredients
- Ocrelizumab
— 40 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninjection.subcutaneous
Solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Ocrevus 920mg/23ml solution for injection vials (Roche Products Ltd)
Ocrevus 920mg/23ml solution for injection vials
- SNOMED code
43146511000001102- Supplier
- Roche Products Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Ocrevus 920mg/23ml solution for injection vials (Roche Products Ltd) 1 vial43146611000001103 ref. pack | 💯 Available Legal category: POM | 076133260757637613326075763 | NHS Indicative Price £9,580 | • Hospital |
| — |
Reference packs
Ocrelizumab 920mg/23ml solution for injection vials 1 vial
- SNOMED code
43146411000001101- Quantity and unit
- 1 vial
- Packs